Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Although treatment of multiple sclerosis (MS) with the type I interferon (IFN) IFN-β lowers disease activity, the role of endogenous type I IFN in MS remains controversial. We studied CD4+ T cells and CD4+ T cell subsets, monocytes and dendritic cells by flow cytometry and analysed the relationship...
Guardado en:
Autores principales: | Finn Sellebjerg, Martin Krakauer, Signe Limborg, Dan Hesse, Henrik Lund, Annika Langkilde, Helle Bach Søndergaard, Per Soelberg Sørensen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a9834ea9d174e548aeecffd4c7d52f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis.
por: Lars Börnsen, et al.
Publicado: (2012) -
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
por: Henrik Lund, et al.
Publicado: (2013) -
The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1.
por: Bjørn A Nexø, et al.
Publicado: (2011) -
Variation in NOD2 augments Th2- and Th17 responses to myelin basic protein in multiple sclerosis.
por: Chris Juul Hedegaard, et al.
Publicado: (2011) -
Neurophysiological changes associated with cortical lesions in multiple sclerosis.
por: Mads Alexander Just Madsen, et al.
Publicado: (2021)